scholarly journals Efficacy and safety of carotid artery stenting for stroke prevention

2016 ◽  
Vol 47 (1) ◽  
pp. 185-192 ◽  
Author(s):  
Ahmed Elserwi ◽  
Talal Amer ◽  
Nermin Soliman ◽  
Ghada M. Gaballa ◽  
Ali H. Elmokadem
2015 ◽  
Vol 17 (suppl A) ◽  
pp. A29-A33 ◽  
Author(s):  
A. Cremonesi ◽  
M. Mussardo ◽  
P. Sbarzaglia ◽  
B. Spagnolo ◽  
C. Cavazza ◽  
...  

2018 ◽  
Vol 173 ◽  
pp. 187-193 ◽  
Author(s):  
Reza Mohammadian ◽  
Ehsan Sharifipour ◽  
Aliakbar Taheraghdam ◽  
Reza Mansourizadeh ◽  
Davar Altafi ◽  
...  

Angiology ◽  
2015 ◽  
Vol 67 (5) ◽  
pp. 408-410 ◽  
Author(s):  
Wesley S. Moore

The superiority of carotid endarterectomy (CEA) plus best medical treatment (BMT) over BMT alone for the management of patients with asymptomatic carotid stenosis is based on randomized controlled trials that recruited patients up to 30 years ago. Best medical treatment has improved considerably since that time with respect to stroke prevention. Furthermore, a new carotid intervention has emerged during the last 2 decades and has gradually become established, that is, carotid artery stenting (CAS). Consequently, the efficacy of current BMT alone needs to be compared not only with CEA plus BMT but also with CAS plus BMT to determine which strategy achieves the optimal stroke prevention rates. This article highlights the purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) 2 and discusses the issues that CREST-2 will hopefully provide answers to.


2017 ◽  
Vol 69 (18) ◽  
pp. 2266-2275 ◽  
Author(s):  
Partha Sardar ◽  
Saurav Chatterjee ◽  
Herbert D. Aronow ◽  
Amartya Kundu ◽  
Preethi Ramchand ◽  
...  

Stroke ◽  
2012 ◽  
Vol 43 (suppl_1) ◽  
Author(s):  
Tomonori Iwata ◽  
Takahisa Mori ◽  
Hiroyuki Tajiri ◽  
Yuichi Miyazaki ◽  
Masahito Nakazaki

Backgrounds and Purpose Transfemoral approach for carotid artery stenting (CAS) is a common technique, but patients must be bedridden for several hours following CAS. If CAS can be performed through the brachial artery route, it is less invasive for patients. The purpose of our study was to investigate the feasibility, efficacy and safety of transbrachial approach for CAS. Materials and Methods Transbrachial approach for CAS was started at October 2010 and data was collected prospectively. Included for analysis were patients who underwent transbrachial elective CAS from October 2010 to July 2011. Every CAS was started through the right brachial route with a 6Fr (ID) guiding sheath specifically designed for the brachial approach under local anesthesia. Technical success, periprocedural complications, 30-day major cardiovascular events (stroke, myocardial infarction and death) and 3- month stent restenosis were investigated. Results Forty-five patients underwent transbrachial CAS. Procedures were successful through the brachial route in every case. Periprocedural complications occurred in three cases; confusion following CAS in one case, hypotension in one case and gastrointestinal hemorrhage in one case. Three patients returned to the previous state within a few days and had no neurological deficits. No access-site related complications occurred. Patients were free on the bed immediately after CAS even during hemostasis. Neither 30- day major cardiovascular events nor 3-month stent restenosis occurred. Conclusions Transbrachial CAS is feasible and safe, and has the same efficacy as transfemoral CAS.


Sign in / Sign up

Export Citation Format

Share Document